Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MOR208
MOR208
MorphoSys and Xencor Publish Final Results from Phase 1/2a Trial of MOR208 (XmAb5574) in CLL/SLL at ASH Annual Meeting
Yahoo/PR Newswire
Sun, 12/7/14 - 10:08 am
MorphoSys
Xencor
MOR208
chronic lymphocytic leukemia
leukemia
US FDA grants fast tract status to MorphoSys's MOR208 programme to treat DLBCL
PharmaBiz
Sat, 11/8/14 - 11:39 am
diffuse large B-cell lymphoma
lymphoma
MorphoSys
MOR208